TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP(C)

Although autologous human mesenchymal stem cells (hMSCs) are a promising source for regenerative stem cell therapy in chronic kidney disease (CKD), the barriers associated with pathophysiological conditions limit therapeutic applicability to patients. We confirmed that level of cellular prion protei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Redox Biol
Main Authors: Yoon, Yeo Min, Kim, SangMin, Han, Yong-Seok, Yun, Chul Won, Lee, Jun Hee, Noh, Hyunjin, Lee, Sang Hun
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6383184/
https://ncbi.nlm.nih.gov/pubmed/30785084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2019.101144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados